Hebei Changshan Biochem Pharma Capital Reinvestment Ratio
Hebei Changshan Biochem Pharma capital reinvestment ratio. Hebei Changshan Biochem Pharma (300255) has a Capital Reinvestment Ratio of 0.27x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥70.22 Million) in capital expenditures (CN¥18.63 Million). Check 300255 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Hebei Changshan Biochem Pharma (2009–2024)
Capital reinvestment ratio of Hebei Changshan Biochem Pharma from 2009 to 2024. This chart tracks Hebei Changshan Biochem Pharma's Capital Reinvestment Ratio across 10 annual periods. Also explore how fast is Hebei Changshan Biochem Pharma growing its equity to track the company's year-over-year net asset growth rate.
Hebei Changshan Biochem Pharma Capital Reinvestment Ratio by Year (2009–2024)
Hebei Changshan Biochem Pharma capital reinvestment ratio by year from 2009 to 2024. For the full cash flow conversion analysis, see Hebei Changshan Biochem Pharma (300255) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 4.26x | CN¥56.22 Million | CN¥239.59 Million | ▼ -39.9% |
| 2023 | 7.10x | CN¥33.73 Million | CN¥239.32 Million | ▼ -94.9% |
| 2022 | 137.97x | CN¥3.13 Million | CN¥431.22 Million | ▲ +28.6% |
| 2021 | 107.29x | CN¥2.87 Million | CN¥308.08 Million | ▲ +13277.0% |
| 2018 | 0.80x | CN¥292.81 Million | CN¥234.85 Million | ▼ -17.8% |
| 2017 | 0.98x | CN¥162.28 Million | CN¥158.30 Million | ▲ +73.8% |
| 2016 | 0.56x | CN¥171.96 Million | CN¥96.52 Million | ▼ -68.6% |
| 2011 | 1.79x | CN¥17.04 Million | CN¥30.43 Million | ▲ +39.0% |
| 2010 | 1.28x | CN¥29.25 Million | CN¥37.56 Million | ▲ +29.3% |
| 2009 | 0.99x | CN¥24.21 Million | CN¥24.05 Million | — |